Making Every Breath Count: The Role of Long-Acting Muscarinic Antagonists in Moderate-to-Severe Asthma

Please join us for our next Pharmacy Resident Seminar Presentation on Tuesday, September 21, 2021, presented by UIC College of Pharmacy PGY2 Ambulatory Care Resident, Sylvia Ou, PharmD.

Type of Activity: Knowledge                                                                                                                             Target Audience: Pharmacists

Time: Tuesday, September 21, 2021,  12:30 pm - 1:20 pm

Fees: There is no charge for attending this activity

Location: Chicago, Room 134-1 and via Zoom

Zoom Meeting Information:
Meeting link: https://go.uic.edu/residentseminar2021-2022
Meeting number: 871 4292 0130
Password: 3Rx8KyKR
Or
Join by phone: 1-312-626-6799 (Chicago)

Learning Objectives :

At the completion of this activity, the participant will be able to:

• Describe recent changes in the GINA report and the NHLBI guidelines for the treatment of moderate-to-severe asthma.
• Summarize current evidence for LAMA addition to ICS/LABA and single inhaler triple therapy ICS/LABA/LAMA in patients with uncontrolled moderate-to-severe asthma.
• Identify patients with uncontrolled asthma on daily ICS/LABA that are most likely to benefit from single inhaler triple therapy.

Disclosure: The speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose.